MGX 10-Q: SEC filing
Metagenomi Therapeutics
Filed with the SEC on · accession 0001193125-26-455441
MGX filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. Metagenomi Therapeutics filed its quarterly 10-Q report for Q3 2026, disclosing financial results including collaboration revenue from its Ionis partnership and its cash position. The stock moved -3.0% by the first close after the filing.
Summary of the filing
Metagenomi Therapeutics filed its quarterly 10-Q report for Q3 2026, disclosing financial results including collaboration revenue from its Ionis partnership and its cash position. The filing contains no single material corporate event such as an executive change, acquisition, or offering.
Key details
How MGX stock reacted
Close before
$0.72
Nov 9, 2026
First close after
-3.01%
$0.70
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for MGX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MGX?
Click hereFrequently asked questions
What did MGX file with the SEC on Nov 10, 2026?
MGX filed a 10-Q (SEC filing). Metagenomi Therapeutics filed its quarterly 10-Q report for Q3 2026, disclosing financial results including collaboration revenue from its Ionis partnership and its cash position. The filing contains no single material corporate event such as an executive change, acquisition, or offering.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did MGX stock react to this filing?
MGX closed at $0.72 before the filing and $0.70 on Nov 10, 2026 (-3.01%).
Other MGX SEC filings
Get alerts when MGX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days